Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?

Wohlfarth K, Sycha T, Ranoux D, Naver H, Caird D

DOI: 10.1185/03007990903028203
Published: 2009 Jul
Container: Current medical research and opinion
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1185/03007990903028203,
  title = {Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?},
  author = {Wohlfarth K and Sycha T and Ranoux D and Naver H and Caird D},
  year = {2009},
  journal = {Current medical research and opinion},
  doi = {10.1185/03007990903028203},
  url = {https://doi.org/10.1185/03007990903028203}
}

RIS

TY  - JOUR
TI  - Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?
AU  - Wohlfarth K
AU  - Sycha T
AU  - Ranoux D
AU  - Naver H
AU  - Caird D
PY  - 2009
JO  - Current medical research and opinion
DO  - 10.1185/03007990903028203
UR  - https://doi.org/10.1185/03007990903028203
ER  -

APA

K, W., T, S., D, R., H, N., & D, C. (2009). Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?. Current medical research and opinion. https://doi.org/10.1185/03007990903028203

Source records

pubmed · retrieved 2026-09-27T08:46:22.932Z